Skip to main content
SpringerLink
Log in

Principle of Radiation Therapy for Gynaecologic Cancers

  • Chapter
  • First Online:
Contemporary Obstetrics and Gynecology for Developing Countries

  • 1180 Accesses

Abstract

After studying this chapter, the reader should be able to:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

    Article  CAS  PubMed  Google Scholar 

  2. Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol Biomark Prev. 2016;25(1):16–27.

    Article  Google Scholar 

  3. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomark Prev. 2005;14(3):677–86.

    Article  Google Scholar 

  4. Munoz N, Bosch FX, de Sanjose S, et al. The role of HPV in the etiology of cervical cancer. Mutat Res. 1994;305(2):293–301.

    Article  CAS  PubMed  Google Scholar 

  5. Mlange R, Matovelo D, Rambau P, et al. Patient and disease characteristics associated with late tumour stage at presentation of cervical cancer in northwestern Tanzania. BMC Womens Health. 2016;16:5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Eze JN, Emeka-Irem EN, Edegbe FO. A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in southeast Nigeria. Clin Med Insights Oncol. 2013;7:151–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Mishra K, Desai A, Patel S, et al. Role of percutaneous nephrostomy in advanced cervical carcinoma with obstructive uropathy: a case series. Indian J Palliat Care. 2009;15(1):37–40.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Gyenwali D, Pariyar J, Onta SR. Factors associated with late diagnosis of cervical cancer in Nepal. Asian Pac J Cancer Prev. 2013;14(7):4373–7.

    Article  PubMed  Google Scholar 

  9. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009;105(2):107–8.

    Article  PubMed  Google Scholar 

  10. Tsikouras P, Zervoudis S, Manav B, et al. Cervical cancer: screening, diagnosis and staging. J BUON. 2016;21(2):320–5.

    PubMed  Google Scholar 

  11. Grigsby PW, Perez CA. Radiotherapy alone for medically inoperable carcinoma of the cervix: stage IA and carcinoma in situ. Int J Radiat Oncol Biol Phys. 1991;21(2):375–8.

    Article  CAS  PubMed  Google Scholar 

  12. Hamberger AD, Fletcher GH, Wharton JT. Results of treatment of early stage I carcinoma of the uterine cervix with intracavitary radium alone. Cancer. 1978;41(3):980–5.

    Article  CAS  PubMed  Google Scholar 

  13. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage IB–IIA cervical cancer. Lancet. 1997;350(9077):535–40.

    Article  CAS  PubMed  Google Scholar 

  14. Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynaecologic Oncology Group study. Gynecol Oncol. 1990;38(3):352–7.

    Article  CAS  PubMed  Google Scholar 

  15. Rotman M, Sedlis A, Piedmonte MR, et al. A phase III randomised trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a Gynaecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 2006;65(1):169–76.

    Article  PubMed  Google Scholar 

  16. Rogers L, Siu SS, Luesley D, et al. Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database Syst Rev. 2012;(5):CD007583.

    Google Scholar 

  17. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–13.

    Article  CAS  PubMed  Google Scholar 

  18. Monk BJ, Wang J, Im S, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynaecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96(3):721–8.

    Article  PubMed  Google Scholar 

  19. Folkert MR, Shih KK, Abu-Rustum NR, et al. Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer. Gynecol Oncol. 2013;128(2):288–93.

    Article  CAS  PubMed  Google Scholar 

  20. Klopp AH, Moughan J, Portelance L, et al. Haematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynaecologic cancer. Int J Radiat Oncol Biol Phys. 2013;86(1):83–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Thomas GM. Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy. N Engl J Med. 1999;340(15):1198–200.

    Article  CAS  PubMed  Google Scholar 

  22. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst Rev. 2010;(1):CD008285.

    Google Scholar 

  23. Rose PG, Ali S, Watkins E, et al. Long-term follow-up of a randomised trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynaecologic Oncology Group study. J Clin Oncol. 2007;25(19):2804–10.

    Article  CAS  PubMed  Google Scholar 

  24. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22(5):872–80.

    Article  PubMed  Google Scholar 

  25. Han K, Milosevic M, Fyles A, et al. Trends in the utilisation of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013;87(1):111–9.

    Article  PubMed  Google Scholar 

  26. Viswanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012;11(1):47–52.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Salani R, Backes FJ, Fung MF, et al. Posttreatment surveillance and diagnosis of recurrence in women with gynaecologic malignancies: Society of Gynaecologic Oncologists recommendations. Am J Obstet Gynecol. 2011;204(6):466–78.

    Article  PubMed  Google Scholar 

  28. American College of Obstetricians and Gynaecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynaecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106(2):413–25.

    Article  Google Scholar 

  29. Espindola D, Kennedy KA, Fischer EG. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia. Obstet Gynecol Clin N Am. 2007;34(4):717–37, ix.

    Article  Google Scholar 

  30. Ronghe R, Gaudoin M. Women with recurrent postmenopausal bleeding should be re-investigated but are not more likely to have endometrial cancer. Menopause Int. 2010;16(1):9–11.

    Article  PubMed  Google Scholar 

  31. Varughese J, Richman S. Cancer care inequity for women in resource-poor countries. Rev Obstet Gynecol. 2010;3(3):122–32.

    PubMed  PubMed Central  Google Scholar 

  32. Brinton LA, Berman ML, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol. 1992;167(5):1317–25.

    Article  CAS  PubMed  Google Scholar 

  33. Woodruff JD, Pickar JH. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group. Am J Obstet Gynecol. 1994;170(5 Pt 1):1213–23.

    Article  CAS  PubMed  Google Scholar 

  34. Schiff I, Sela HK, Cramer D, et al. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril. 1982;37(1):79–82.

    Article  CAS  PubMed  Google Scholar 

  35. Furness S, Roberts H, Marjoribanks J, et al. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2009;(2):CD000402.

    Google Scholar 

  36. Iqbal J, Ginsburg OM, Wijeratne TD, et al. Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treat Rev. 2012;38(4):318–28.

    Article  CAS  PubMed  Google Scholar 

  37. Early Breast Cancer Trialists’ Collaborative Group, Davies C, Godwin J, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771–84.

    Article  CAS  Google Scholar 

  38. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45(1 Suppl):277–82.

    Article  CAS  PubMed  Google Scholar 

  39. La Vecchia C, Franceschi S, Decarli A, et al. Risk factors for endometrial cancer at different ages. J Natl Cancer Inst. 1984;73(3):667–71.

    PubMed  Google Scholar 

  40. Hoffman BLSJ, Bradshaw KD, Halvorson LM, Scahffer JI, Corton MM. Williams gynaecology. 3rd ed. New York: McGraw-Hill; 2016.

    Google Scholar 

  41. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynaecologic Oncology Group study. Cancer. 1987;60(8 Suppl):2035–41.

    Article  CAS  PubMed  Google Scholar 

  42. Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008;109(1):11–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. ASTEC Study Group, Kitchener H, Swart AM, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–36.

    Article  Google Scholar 

  44. Resnick KE, Cohn DE, Fowler JM. Role of lymphadenectomy in the staging of endometrial cancer. Nat Rev Clin Oncol. 2009;6(7):382–4.

    Article  PubMed  Google Scholar 

  45. Creutzberg CL, Nout RA, Lybeert ML, et al. Fifteen-year radiotherapy outcomes of the randomised PORTEC-1 trial for endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2011;81(4):e631–8.

    Article  PubMed  Google Scholar 

  46. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynaecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744–51.

    Article  PubMed  Google Scholar 

  47. Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375(9717):816–23.

    Article  CAS  PubMed  Google Scholar 

  48. Randall ME, Filiaci VL, Muss H, et al. Randomised phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynaecologic Oncology Group study. J Clin Oncol. 2006;24(1):36–44.

    Article  CAS  PubMed  Google Scholar 

  49. Susumu N, Sagae S, Udagawa Y, et al. Randomised phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynaecologic Oncology Group study. Gynecol Oncol. 2008;108(1):226–33.

    Article  CAS  PubMed  Google Scholar 

  50. Kuoppala T, Maenpaa J, Tomas E, et al. Surgically staged high-risk endometrial cancer: randomised study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy. Gynecol Oncol. 2008;110(2):190–5.

    Article  PubMed  Google Scholar 

  51. Hogberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies. Eur J Cancer. 2010;46(13):2422–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. PORTEC-3 Trial. http://clinicaltrials.gov/ct2/show/NCT00411138.

  53. GOG 258. http://clinicaltrials.gov/ct2/show/NCT00942357.

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Medicine, Oregon Health and Science University, Portland, OR, USA

    Shushan Rana, Sophia Bornstein & Jerry J. Jaboin

Authors
  1. Shushan Rana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sophia Bornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jerry J. Jaboin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jerry J. Jaboin .

Editor information

Editors and Affiliations

  1. Centre of Excellence in Reproductive Health Innovation, Department of Obstetrics and Gynaecology, University of Benin, Benin City, Nigeria

    Friday Okonofua

  2. College of Health Sciences, Chicago State University, Chicago, IL, USA

    Joseph A. Balogun

  3. Roswell Park Cancer Institute, Buffalo, NY, USA

    Kunle Odunsi

  4. Clinical Obstetrics and Gynaecology, Weil Cornell Medicine, Doha, Qatar

    Victor N. Chilaka

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rana, S., Bornstein, S., Jaboin, J.J. (2021). Principle of Radiation Therapy for Gynaecologic Cancers. In: Okonofua, F., Balogun, J.A., Odunsi, K., Chilaka, V.N. (eds) Contemporary Obstetrics and Gynecology for Developing Countries . Springer, Cham. https://doi.org/10.1007/978-3-030-75385-6_60

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-75385-6_60

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-75384-9

  • Online ISBN: 978-3-030-75385-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation